Bullboard - Stock Discussion Forum Vaxart Inc VXRT

Healthcare Biotechnology

Vaxart, Inc. is a clinical-stage biotechnology company that is primarily focused on the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology (VAAST) proprietary oral vaccine platform. Its vaccines are designed to be administered using pills that can be stored and shipped without refrigeration and eliminate the risk of needle-stick injury. Its... see more

Add To Watchlist

NDAQ:VXRT - Post Discussion

Vaxart Inc > VXRT - Institutional Investors

View:

Post by thevisionary2k on Feb 12, 2021 8:32am

VXRT - Institutional Investors

Let’s put into perspective the VXRT-State Street, BlackRock and Vanguard investments - three (3) of largest asset management and investment firms in the world with $18 Trillion in Assets.

State Street:

Total Assets: $3.2 Trillion
VXRT Shares: 9.5 Million
VXRT Share % Change: 33,072%
Current VXRT Market Value: $81.8 Million

BlackRock

Total Assets: $8.7 Trillion
VXRT Shares: 4.9 Million
VXRT Share % Change: 645%
Current VXRT Market Value: $42.8 Million

Vanguard Group

Total Assets: $6.2 Trillion
VXRT Shares: 5.0 Million
VXRT Share % Change: 27%
Current VXRT Market Value: $43.3 Million

Combined, the Current VXRT Market Value is $167.9 Million, equating to 20.4 million shares owned, while their VXRT share percentage change ranges from 27% - 33,072%.

State Street, BlackRock and Vanguard would not have increased its investments in VXRT without performing proper due diligence.

326